- Home
- WIA vs BDTX Comparison
WIA vs BDTX Comparison
Compare WIA & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIA
- BDTX
- Stock Information
- Founded
- WIA 2003
- BDTX 2014
- Country
- WIA United States
- BDTX United States
- Employees
- WIA N/A
- BDTX N/A
- Industry
- WIA Trusts Except Educational Religious and Charitable
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WIA Finance
- BDTX Health Care
- Exchange
- WIA Nasdaq
- BDTX Nasdaq
- Market Cap
- WIA 196.4M
- BDTX 181.4M
- IPO Year
- WIA N/A
- BDTX 2020
- Fundamental
- Price
- WIA $8.41
- BDTX $2.80
- Analyst Decision
- WIA
- BDTX Strong Buy
- Analyst Count
- WIA 0
- BDTX 5
- Target Price
- WIA N/A
- BDTX $13.40
- AVG Volume (30 Days)
- WIA 39.2K
- BDTX 864.1K
- Earning Date
- WIA 01-01-0001
- BDTX 08-07-2025
- Dividend Yield
- WIA 12.29%
- BDTX N/A
- EPS Growth
- WIA N/A
- BDTX N/A
- EPS
- WIA N/A
- BDTX 0.25
- Revenue
- WIA N/A
- BDTX $70,000,000.00
- Revenue This Year
- WIA N/A
- BDTX N/A
- Revenue Next Year
- WIA N/A
- BDTX N/A
- P/E Ratio
- WIA N/A
- BDTX $11.22
- Revenue Growth
- WIA N/A
- BDTX N/A
- 52 Week Low
- WIA $7.56
- BDTX $1.20
- 52 Week High
- WIA $8.91
- BDTX $6.33
- Technical
- Relative Strength Index (RSI)
- WIA 56.05
- BDTX 52.14
- Support Level
- WIA $8.29
- BDTX $2.56
- Resistance Level
- WIA $8.41
- BDTX $2.98
- Average True Range (ATR)
- WIA 0.05
- BDTX 0.16
- MACD
- WIA 0.01
- BDTX 0.01
- Stochastic Oscillator
- WIA 61.90
- BDTX 49.90
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.